Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Kanerva

Showing results (71-80 of 124) with videos related to

Pageof 13
Sort By:
Journal for Immunotherapy of Cancer|January 16, 2020
Oncolytic adenovirus shapes the ovarian tumor microenvironment for potent tumor-infiltrating lymphocyte tumor reactivityJoão Manuel Santos, Camilla Heiniö, Victor Cervera-Carrascon, et al.
Molecular Pharmaceutics|October 23, 2010
Safety of glucocorticoids in cancer patients treated with oncolytic adenovirusesMaria Rajecki, Mari Raki, Sophie Escutenaire, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 25, 2002
Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenovirusesAnna Kanerva, Minghui Wang, Gerd J Bauerschmitz, et al.
Molecular Therapy Oncolytics|March 28, 2017
Oncolytic Adenoviruses Armed with Tumor Necrosis Factor Alpha and Interleukin-2 Enable Successful Adoptive Cell TherapyRiikka Havunen, Mikko Siurala, Suvi Sorsa, et al.
Molecular Cancer Therapeutics|February 20, 2007
Treatment of prostate cancer with Ad5/3Delta24hCG allows non-invasive detection of the magnitude and persistence of virus replication in vivoMaria Rajecki, Anna Kanerva, Ulf-Håkan Stenman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2006
Infectivity-enhanced adenoviruses deliver efficacy in clinical samples and orthotopic models of disseminated gastric cancerLotta Kangasniemi, Tuula Kiviluoto, Anna Kanerva, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 7, 2015
T-cell subsets in peripheral blood and tumors of patients treated with oncolytic adenovirusesKristian Taipale, Ilkka Liikanen, Juuso Juhila, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 28, 2011
Induction of interferon pathways mediates in vivo resistance to oncolytic adenovirusIlkka Liikanen, Vladia Monsurrò, Laura Ahtiainen, et al.
Cancer Research|July 18, 2008
Tissue-specific promoters active in CD44+CD24-/low breast cancer cellsGerd J Bauerschmitz, Tuuli Ranki, Lotta Kangasniemi, et al.
The Journal of Gene Medicine|April 15, 2003
The secretory leukoprotease inhibitor (SLPI) promoter for ovarian cancer gene therapyShannon D Barker, Candace J Coolidge, Anna Kanerva, et al.
Pageof 13

Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
Journal for Immunotherapy of Cancer|January 16, 2020
Oncolytic adenovirus shapes the ovarian tumor microenvironment for potent tumor-infiltrating lymphocyte tumor reactivityJoão Manuel Santos, Camilla Heiniö, Victor Cervera-Carrascon, et al.
Molecular Pharmaceutics|October 23, 2010
Safety of glucocorticoids in cancer patients treated with oncolytic adenovirusesMaria Rajecki, Mari Raki, Sophie Escutenaire, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 25, 2002
Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenovirusesAnna Kanerva, Minghui Wang, Gerd J Bauerschmitz, et al.
Molecular Therapy Oncolytics|March 28, 2017
Oncolytic Adenoviruses Armed with Tumor Necrosis Factor Alpha and Interleukin-2 Enable Successful Adoptive Cell TherapyRiikka Havunen, Mikko Siurala, Suvi Sorsa, et al.
Molecular Cancer Therapeutics|February 20, 2007
Treatment of prostate cancer with Ad5/3Delta24hCG allows non-invasive detection of the magnitude and persistence of virus replication in vivoMaria Rajecki, Anna Kanerva, Ulf-Håkan Stenman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2006
Infectivity-enhanced adenoviruses deliver efficacy in clinical samples and orthotopic models of disseminated gastric cancerLotta Kangasniemi, Tuula Kiviluoto, Anna Kanerva, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 7, 2015
T-cell subsets in peripheral blood and tumors of patients treated with oncolytic adenovirusesKristian Taipale, Ilkka Liikanen, Juuso Juhila, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 28, 2011
Induction of interferon pathways mediates in vivo resistance to oncolytic adenovirusIlkka Liikanen, Vladia Monsurrò, Laura Ahtiainen, et al.
Cancer Research|July 18, 2008
Tissue-specific promoters active in CD44+CD24-/low breast cancer cellsGerd J Bauerschmitz, Tuuli Ranki, Lotta Kangasniemi, et al.
The Journal of Gene Medicine|April 15, 2003
The secretory leukoprotease inhibitor (SLPI) promoter for ovarian cancer gene therapyShannon D Barker, Candace J Coolidge, Anna Kanerva, et al.
Pageof 13